Search through all our worldwide HIV and AIDS news and features, using the topics below to filter your results by subjects including HIV treatment, transmission and prevention, and hepatitis and TB co-infections.

PrEP news

Show

From To
PrEP campaigns must include youth, communities of color

Sandy Close, moderating a panel on how to close the information gap on PrEP in underserved communities, called it a “break the silence issue,” referring to the stigma and misconceptions about PrEP and HIV. Misinformation about the drug is all too rampant. Too many from communities of color believe the drug is not for them.

Published
19 November 2017
From
San Francisco Examiner
New Zealand AIDS Foundation welcomes PHARMAC’s milestone proposal to fund Pre-exposure Prophylaxis (PrEP)

In a proposal released today, PHARMAC has announced its intention to fund the HIV-prevention drug PrEP – meaning the medicine is one step closer to becoming available to those at highest risk of HIV in New Zealand.

Published
14 November 2017
From
New Zealand AIDS Foundation
British Columbia just lost its last two excuses not to cover the pill that prevents HIV

Julio Montaner, the head of the BC Centre for Excellence in HIV/AIDS, told a room full of doctors and activists Nov 6, 2017, that his centre has negotiated a deal with generic drug manufacturers that could deliver the treatment without swelling the budget. “The message is, we’re ready,” Montaner told Xtra following his announcement. “It’s time to do this.”

Published
13 November 2017
From
XTRA, Vancouver
Danish court invalidates Gilead SPC

The Danish Maritime and Commercial High Court has invalidated a supplementary protection certificate (SPC) owned by Gilead. On October 26, the court rejected Gilead’s motion for an injunction against generics maker Accord.

Published
10 November 2017
From
Life Sciences Intellectual Property Review
Ireland’s first clinic monitoring anti-HIV drug PrEP opens

The clinic will be open to users of the drug and will provide HIV tests and STI screening; it will not supply the drug.

Published
10 November 2017
From
The Irish Times
Gilead loss of generic HIV drug battle a boost for gay community

Published
09 November 2017
From
The Irish Times
The future of PrEP in Australia

PrEP has been a major discussion point in the 2017 ASHM conference. In a joint symposium with the 2017 Sexual Health Conference, multiple speakers spoke of the rollout of PrEP in Australia and New Zealand.

Published
08 November 2017
From
Australian Society for HIV Medicine Report Back
PrEP and reaching people of color, trans women, and young people

Not everyone at risk for HIV knows about PrEP, and many people who could benefit from PrEP believe it’s not for them. A recent panel discussion in San Francisco explored this issue. Speaking about their work and the diverse communities they serve, the panelists shared some of the important barriers that people of color, trans women and young people face related to PrEP knowledge, access and adherence.

Published
08 November 2017
From
BETA blog
I’m one of the people in England trialling a new drug that virtually stops the spread of HIV

There’s a quiet revolution going on in sexual health at the moment. I’m one of thousands of people are taking a pill every day to stop unwanted consequences of sex.

Published
07 November 2017
From
The Overtake
Uptake of medications for HIV treatment and prevention changes sexual practices

The Annual Report of Trends in Behaviour 2017 released today by the Centre for Social Research in Health (CSRH) at UNSW Sydney finds the proportion of non-HIV-positive gay men who reported pre-exposure prophylaxis (PrEP) use in the six months prior to the annual Gay Community Periodic Surveys increased from 2% in 2013 to 5% in 2016.

Published
06 November 2017
From
University of New South Wales
← First12345...97Next →

Filter by country

Community Consensus Statement on Access to HIV Treatment and its Use for Prevention

Together, we can make it happen

We can end HIV soon if people have equal access to HIV drugs as treatment and as PrEP, and have free choice over whether to take them.

Launched today, the Community Consensus Statement is a basic set of principles aimed at making sure that happens.

The Community Consensus Statement is a joint initiative of AVAC, EATG, MSMGF, GNP+, HIV i-Base, the International HIV/AIDS Alliance, ITPC and NAM/aidsmap
close

This content was checked for accuracy at the time it was written. It may have been superseded by more recent developments. NAM recommends checking whether this is the most current information when making decisions that may affect your health.

NAM’s information is intended to support, rather than replace, consultation with a healthcare professional. Talk to your doctor or another member of your healthcare team for advice tailored to your situation.